CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Wednesday reported a loss of $77.1 million in its third quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.59.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.74 per share.
The biopharmaceutical company posted revenue of $11.4 million in the period, which met Street forecasts.
Agios Pharmaceuticals shares have climbed 54 percent since the beginning of the year. The stock has increased 34 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGIO at https://www.zacks.com/ap/AGIO